1. UCL Home
  2. Research institutes
  3. Louvain Drug Research Institute
  4. Research groups
  5. Advanced Drug Delivery and Biomaterials (ADDB)
  6. Theses

Theses

Bruxelles Woluwe

THESES IN PROGRESS

Auquière Marie
Encapsulation of lipids and microARNs in extracellular vesicles for the treatment of multiple sclerosis
Directors : Anne des Rieux and Giulio Muccioli

Cheng Chen
Metal-organic framework for oral antibody delivery for inflammatory bowel disease and colorectal cancer treatment
Director : Ana Beloqui Garcia

Debuisson Floriane
Mesenchymal stem cells delivery in hybrid spheroids for treatment of spinal cord injury: innovative formulation and pre-clinical perspectives.”
Director: Anne des Rieux (ADDB/LDRI)

Detroz Fanny
Development of nanomedicines to tackle cystic fibrosis lung disease
Directors Rita Vanbever and Mireille Dumoulin (ULiège)

Hendrickx Pauline
Programmable Biomaterials Laboratory/EPFL - Exploring the use of DNA nanotechnology for the cytoplasmic delivery of therapeutic miRNA for spinal cord injury repair
Director : Anne des Rieux

Hoflack Laurie
Development and pharmacological assessment of a dual nanocarrier containing pro-resolutive drugs in models of rheumatoid arthritis
Directors : Mireille Al Houayek and Ana Beloqui Garcia

Ladeiro Domingues Inês
Exploiting the biological effect exerted by nanocarriers in non-alcoholic fatty liver disease treatment.
Director: Ana Beloqui (ADDB/LDRI); Co-Director: Isabelle Leclercq (GAEN/IREC)

Leone Giuditta
Design of a long-acting vasodilator nanomedicine for inhalation in pulmonary arterial hypertension.
Director: Rita Vanbever (ADDB/LDRI) - Co-Director: Raphaël Frédérick (CMFA/LDRI)

Ma Zhanjun
Taking the best of two worlds to treat spinal cord injury: traditional Chinese medicine Rosmarinic acid combined with stem cell derived-extracellular vesicles
Director : Anne des Rieux

Marotti Valentina
Gene silencing of TNFα in inflammatory bowel disease treatment through a dual-shielding strategy via bioadhesive beads”.
Director: Ana Beloqui (ADDB/LDRI); Co-Director: Alessio Malfanti (ADDB/LDRI)

Redeghieri Paola
Nanobodies to target proteases involved in inflammatory diseases of the lungs
Director: Mireille Dumoulin (Center for protein engineering, ULiège); Co-Director: Rita Vanbever (ADDB/LDRI)

Yang Jingjing
Development of rationally-designed stimuli-responsive nanoparticles for neuroprotective purposes in spinal cord injury repair
Directors : Anne des Rieux and Giulio Muccioli

Zhang Wunan
Local delivery of an anti-TNF-α monoclonal antibody in the treatment of inflammatory bowel diseases using foam-based drug delivery system
Director: Ana Beloqui (ADDB/LDRI)